The lack of correlation between SLs and likelihood of pCR in our study is in contrast to that observed in other HER2-positive or triple negative breast cancer studies, where SLs are an independent predictive marker of pCR [15, 16]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.